Background Elevated levels of inflammatory factors are associated with poor prognosis in
coronavirus disease-19 (COVID-19). However, mesenchymal stem cells (MSCs) have …

OBJECTIVES: The coronavirus disease (COVID-19) outbreak has catastrophically
threatened public health worldwide and presented great challenges for clinicians. To date …

Acute respiratory distress syndrome (ARDS) in COVID-19 is associated with high mortality.
Mesenchymal stem cells are known to exert immunomodulatory and anti-inflammatory …

No effective drug treatments are available for coronavirus disease 2019 (COVID-19). Host-
directed therapies targeting the underlying aberrant immune responses leading to …

Objectives A major challenge for COVID-19 therapy is dysregulated immune response
associated with the disease. Umbilical cord mesenchymal stromal cells (UC-MSCs) may be …

Background The novel coronavirus is still mutating, and the pandemic continues.
Meanwhile, many COVID-19 survivors have residual postinfection clinical manifestations …

Background: Treatment of severe Corona Virus Disease 2019 (COVID-19) is challenging.
We performed a phase 2 trial to assess the efficacy and safety of human umbilical cord …

Background: Acute Respiratory Distress Syndrome (ARDS) in COVID-19 is associated with
high mortality. Mesenchymal Stem Cells (MSC) are potent immunomodulatory cells. The aim …

Objective: Mesenchymal stem cells can serve as a therapeutic option for COVID-19. Their
immunomodulatory and anti-inflammatory properties can regulate the exaggerated …

Previously, we demonstrated the therapeutic effects of human umbilical cord mesenchymal
stromal cells (hUC-MSCs) in severe coronavirus disease 2019 (COVID-19) patients. In this 3 …